![]() |
½ÃÀ庸°í¼
»óÇ°ÄÚµå
1426958
ÀÚ°¡ °Ë»ç ½ÃÀå : Á¦Ç° À¯Çüº°, »ùÇà À¯Çüº°, ¿ëµµº°, °Ë»ç À¯Çüº°, À¯Åë ä³Îº° - ¼¼°è ¿¹Ãø(2024-2032)Self-testing Market - By Product Type (Kits, Devices, Strips), Sample Type (Blood, Urine), Usage (Disposable, Reusable), By Application (Blood Glucose Test, Pregnancy Test, Allergy Test), Test Type, Distribution Channel - Global Forecast 2024-2032 |
¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀåÀº ¿¹¹æ ÇコÄɾ ´ëÇÑ ÀǽÄÀÇ Çâ»ó, ±â¼úÀÇ Áøº¸, ÇöÀç ¼¼°èÀÇ °Ç° »óȲ¿¡ ÀÇÇØ ÃËÁøµÇ¾î 2024-2032³â CAGR 6.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
IDF ´ç´¢º´ ¾ÆƲ¶ó½º Á¦10ÆÇ¿¡ µû¸£¸é 2021³â¿¡´Â 20-79¼¼ ¼ºÀÎÀÌ 5¾ï 3,700¸¸ ¸í, 10¸í´ç 1¸íÀÌ ´ç´¢º´À¸·Î ÀÌȯÇÏ°í ÀÖÀ¸¸ç, 2030³â¿¡´Â 6¾ï 4,300¸¸ ¸í, 2045³â¿¡´Â 7¾ï 8,300¸¸ ¸íÀ¸·Î Áõ°¡ ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ç´¢º´ ¹× ±âŸ »ýÈ°½À°üº´ Áõ°¡¿Í Á¶±â ¹ß°ß ¹× ÀÚ°¡ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÀÚ°¡ °Ë»ç Å°Æ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. Á¤º¸¿¡ ´ëÇÑ Á¢±Ù¼º Áõ°¡·Î ÀÎÇÑ °Ç° ÀÎ½Ä Áõ°¡´Â »ç¶÷µéÀÌ Á¤±âÀûÀ¸·Î °Ç°À» ¸ð´ÏÅ͸µÇϵµ·Ï Àå·ÁÇÏ°í ÀÖ½À´Ï´Ù.
´Ù¿ëµµ¼º, ±â¼ú ÅëÇÕ ¹× Áö¼ÓÀûÀÎ °ü·Ã¼º¿¡ ÈûÀÔ¾î 2032³â±îÁö ±â±â ºÐ¾ß´Â °ßÀηÂÀ» ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ç÷´ç ÃøÁ¤±âºÎÅÍ ÀӽŠÅ×½ºÆ®±â±îÁö ÀÌ·¯ÇÑ ±â±âµéÀº Æí¸®ÇÔÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÀÚ°¡ Áø´Ü ±â±â¿¡ ½º¸¶Æ®Æù ¿¬°á°ú ¾ÛÀÇ ÅëÇÕÀº Àü¹ÝÀûÀÎ »ç¿ëÀÚ °æÇèÀ» Çâ»ó½ÃÄÑ °³ÀÎÀÌ À̵¿ Áß¿¡µµ ¿øÈ°ÇÏ°Ô °Ç° »óŸ¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
Ÿ¾× »ùÇà À¯Çü ºÎ¹®Àº ºñħ½ÀÀû Ư¼º°ú äÃëÀÇ ¿ëÀ̼ºÀ¸·Î ÀÎÇØ 2032³â±îÁö °¢±¤À» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âÁ¸ÀÇ Ç÷¾× ±â¹Ý °Ë»ç´Â Ç÷¾× äÃë¿¡ µû¸¥ ºÒÆíÇÔÀ¸·Î ÀÎÇØ Á¤±âÀûÀÎ °Ë»ç¸¦ ±âÇÇÇÏ´Â °æÇâÀÌ ÀÖ¾ú½À´Ï´Ù. Ÿ¾× ±â¹Ý °Ë»ç´Â ÀÌ·¯ÇÑ À庮À» ¾ø¾Ö°í °íÅ뽺·´Áö ¾Ê°í Æí¸®ÇÑ ´ë¾ÈÀ» Á¦°øÇϸç, DNA °Ë»ç ¹× °¨¿°¼º Áúȯ °ËÃâÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ °Ç° ¸Å°³ º¯¼ö¿¡ ´ëÇÑ ÀÌ·¯ÇÑ °Ë»çÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ È®´ë¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÚ°¡Áø´Ü ½ÃÀåÀº Áß»êÃþ Áõ°¡¿Í ÇコÄɾ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¿¹Ãø ±â°£ Áß ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª Á¤ºÎµµ ¿¹¹æ ÀÇ·á ´ëÃ¥ ÃßÁø¿¡ ÁÖ·ÂÇÏ°í ÀÖ½À´Ï´Ù. Áß±¹°ú Àεµ¿Í °°ÀÌ Àα¸ ±â¹ÝÀÌ Å« ±¹°¡¿¡¼´Â µµ½ÃÈ, °¡Ã³ºÐ ¼Òµæ Áõ°¡, °Ç°¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀ¸·Î ÀÎÇØ ÀÚ°¡ °Ë»ç ÀåºñÀÇ µµÀÔÀÌ ±ÞÁõÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ´Â APAC Áö¿ªÀÌ ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ±æ·Î ÀÚ¸®¸Å±èÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
The global self-testing market is expected to grow at a CAGR of 6.7% during 2024-2032, driven by the increasing awareness of preventive healthcare, technological advancements, and the current global health landscape.
According to IDF Diabetes Atlas 10th edition, in 2021, 537 million adults aged between 20 and 79 were affected by diabetes, equating to one in every ten individuals, with projections indicating a rise to 643 million by 2030 and 783 million by 2045. The increasing case of diabetes and other lifestyle diseases, in consort with cognizance of early detection as well as self-monitoring are boosting the demand for self-testing kits. The rise in health consciousness, fueled by increased access to information, is encouraging people to monitor their health regularly..
The overall self-testing market is classified based on product type, sample type, usage, application test type, distribution channel, and region.
The devices segment is set to gain traction through 2032, propelled by versatility, technology integration, and sustained relevance. These devices ranging from glucose monitors to pregnancy tests, offer convenience. Moreover, the integration of smartphone connectivity and apps in self-testing devices is enhancing the overall user experience, making it seamless for individuals to monitor their health on the go.
The saliva sample type segment is poised to gain prominence till 2032, due to its non-invasive nature and ease of collection. Traditional blood-based tests often deter individuals from regular testing due to the discomfort associated with drawing blood. Saliva-based tests eliminate this barrier, offering a painless and convenient alternative. The increasing adoption of these tests for various health parameters, including DNA testing and infectious disease detection, is contributing to the expansion of this segment.
Asia Pacific self-testing market is anticipated to grow at a steady pace during the forecast period, driven by the rising healthcare awareness, coupled with a growing middle-class population. Governments in the region are also focusing on promoting preventive healthcare measures. Countries like China and India, with a large population base, are witnessing a surge in the adoption of self-testing devices, driven by urbanization, increasing disposable income, and a proactive approach to health. This will position the APAC region as a lucrative avenue for the market players.